Omar Eduardo Fernandez Vargas

Dr. Omar Eduardo Fernandez Vargas

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Hematology
Verified
Journal Article
Open access
CVCésar Jonathan Vargas-Carretero
César Jonathan Vargas-Carretero
OVOmar Eduardo Fernandez Vargas
Omar Eduardo Fernandez Vargas
ARAna Lucía Ron-Magaña
Ana Lucía Ron-Magaña
JPJosé Alejandro Padilla-Ortega
José Alejandro Padilla-Ortega
CRCarlos Silvestre Ron-Guerrero
Carlos Silvestre Ron-Guerrero
EBEsperanza Barrera-Chairez
Esperanza Barrera-Chairez
BackgroundPancytopenia is a frequent entity in clinical practice as a feature of a myriad of conditions, ranging from benign to malignant diseases. Since the cause of pancytopenia depends on environmental factors, it is important to know the common etiologies of pancytopenia, however, few studies address this.ObjectivesTo identify the etiology of pancytopenia in our population and compare them with what is reported elsewhere.MethodsWe conducted an observational study of patients with pancytopenia in a Mexican Tertiary Care Center. Clinical, hematological and bone marrow studies were performed in all patients.ResultsOf 109 cases included, the mean age at diagnosis was 49.4 years, with a slightly higher female incidence (53.2%). The most common causes of pancytopenia were: MDS (20.2%), megaloblastic anemia (18.3%) and AML (12.8%).DiscussionWe found a complex picture of pancytopenia in Mexico and compared it with what is reported elsewhere in the literature.ConclusionThe sociocultural context in whic...

27 October 2016 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
JHJosé Antonio Hernández-Trejo
José Antonio Hernández-Trejo
DSDimelza Suárez-Pérez
Dimelza Suárez-Pérez
IGItzel Zenidel Gutiérrez-Martínez
Itzel Zenidel Gutiérrez-Martínez
OVOmar Eduardo Fernandez Vargas
Omar Eduardo Fernandez Vargas
CSCarolina Serrano
Carolina Serrano
PNPorfirio Nava
Porfirio Nava
The gastrointestinal tract is the largest hormone-producing organ in the body due to a specialized cell population called enteroendocrine cells (EECs). The number of EECs increases in the mucosa of inflammatory bowel disease patients; however, the mechanisms responsible for these changes remain unknown. Here, we show that the pro-inflammatory cytokines interferon γ (IFNγ) and tumor necrosis factor α (TNFα) or dextran sulfate sodium (DSS)-induced colitis increase the number of EECs producing chromogranin A (CgA) in the colonic mucosa of C57BL/6J mice. CgA-positive cells were non-proliferating cells enriched with inactive phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and autophagy markers. Moreover, inhibition of Akt and autophagy prevented the increase in CgA-positive cells after IFNγ/TNFα treatment. Similarly, we observed that CgA-positive cells in the colonic mucosa of patients with colitis expressed Akt and autophagy markers. These findings suggest that Akt signaling and autophagy control differentiation of the intestinal EEC lineage during inflammation.

18 July 2012 in Hematology
Verified
Journal Article
Closed access
GRGuillermo J Ruiz-Delgado
Guillermo J Ruiz-Delgado
DGDavid Gómez-Almaguer
David Gómez-Almaguer
LTLuz C Tarín-Arzaga
Luz C Tarín-Arzaga
OCOlga G Cantú-Rodriguez
Olga G Cantú-Rodriguez
CUCarlos Alarcón Urdaneta
Carlos Alarcón Urdaneta
GRGuillermo José Ruiz-Argüelles
Guillermo José Ruiz-Argüelles
Rituximab (R) has changed the prognosis of patients with non-Hodgkin's lymphoma (NHL) in developed countries, but its role has not been analyzed in underprivileged circumstances. One hundred and two patients with NHL treated in a developing country were analyzed: 28 patients with follicular lymphoma (FL) and 74 with diffuse large B-cell lymphoma (DLCL). Patients were treated upfront with either cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP; the decision to employ R depending solely on the ability of patients to defray it. In DLCL, 42 were given CHOP and 32 R-CHOP, whereas in FL, 19 were given CHOP and 9 R-CHOP. The impact of the addition of R was found to be clearer in FL than in DLCL. In patients with DLCL, the overall survival (OS) was 87% at 80 months for those treated with R-CHOP and 84% at 145 months for those treated with CHOP (not significant). In patients with FL, the OS was 89% at 88 months for those treated with R-CHOP and 71% at 92 months for those treated with CHOP (P = 0··05). In a multivariate analysis, other variables which were identified to be associated with the OS were IPI and number of cycles in DLCL. It is concluded that R produced a mild positive impact in the OS of patients with FL, but not in those with DLCL. Since the addition of R results in a 36-fold increase in treatment costs, these observations may be important to decide therapeutic approaches in NHL patients living in underprivileged circumstances.

22 October 2019 in Annals of Transplantation
Verified
Journal Article
Closed access
PDF file
ARAna Lucia Ron-Magaña
Ana Lucia Ron-Magaña
OVOmar Eduardo Fernandez Vargas
Omar Eduardo Fernandez Vargas
EBEsperanza Barrera-Chairez
Esperanza Barrera-Chairez
CRCarlos Silvestre Ron-Guerrero
Carlos Silvestre Ron-Guerrero
ABAna Jaqueline Bañuelos-Ávila
Ana Jaqueline Bañuelos-Ávila
BACKGROUND High-dose chemotherapy followed by autologous hematopoietic stem cell transplant has proven useful in relapsed or refractory cases of Hodgkin and non-Hodgkin lymphoma. BEAM (carmustine, etoposide, cytarabine, melphalan) is frequently used as a conditioning regimen; however, the high cost and limited availability of BCNU hinders its use in Mexico. MATERIAL AND METHODS Between January 2013 and February 2019, refractory or relapsing HL and NHL patients were treated with an autologous HSCT conditioned with cisplatin+dexamethasone as substitution for BCNU in BEAM. RESULTS Four HL patients and 6 NHL patients were included; 60% were male, the average age was 34.5±15.2 years, the median follow-up was 19.1 months, and 70% had a complete response after transplant. OS at 12 months was 63% for NHL and 100% for HL. Time to hematological recovery was 17.6±2.8 days; all patients developed grade III/IV neutropenia and thrombocytopenia, and 8 patients had transplant-related infections. CONCLUSIONS This retrospective study based on real-world data introduces the option of substituting carmustine with cisplatin+dexamethasone, with a similar response, expected lower cost, and better accessibility in developing nations.

30 December 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
DRDaniel Rembao-Bojórquez
Daniel Rembao-Bojórquez
Carlos Sánchez-GaribayCarlos Sánchez-Garibay
Carlos Sánchez-Garibay
CSCitlaltepetl Salinas-Lara
Citlaltepetl Salinas-Lara
BMBrenda Marquina-Castillo
Brenda Marquina-Castillo
ALAdriana Letechipía-Salcedo
Adriana Letechipía-Salcedo
Rogelio Hernández-PandoRogelio Hernández-Pando
Rogelio Hernández-Pando
Tuberculosis (TB) of the central nervous system (CNS) is a lethal and incapacitating disease. Several studies have been performed to understand the mechanism of bacterial arrival to CNS, however, it remains unclear. Although the interaction of the host, the pathogen, and the environment trigger the course of the disease, in TB the characteristics of these factors seem to be more relevant in the genesis of the clinical features of each patient. We previously tested three mycobacterial clinical isolates with distinctive genotypes obtained from the cerebrospinal fluid of patients with meningeal TB and showed that these strains disseminated extensively to the brain after intratracheal inoculation and pulmonary infection in BALB/c mice. In this present study, BALB/c mice were infected through the intranasal route. One of these strains reaches the olfactory bulb at the early stage of the infection and infects the brain before the lungs, but the histological study of the nasal mucosa did not show any alteration. This observation suggests that some mycobacteria strains can arrive directly at the brain, apparently toward the olfactory nerve after infecting the nasal mucosa, and guides us to study in more detail during mycobacteria infection the nasal mucosa, the associated connective tissue, and nervous structures of the cribriform plate, which connect the nasal cavity with the olfactory bulb.

27 July 2024 in Transplantation Proceedings
Verified
Journal Article
Closed access
BAB.L. Acosta-Maldonado
B.L. Acosta-Maldonado
APA. Padilla-Ortega
A. Padilla-Ortega
OVOmar Eduardo Fernandez Vargas
Omar Eduardo Fernandez Vargas
LRL. Rivera-Fong
L. Rivera-Fong
LVL.M. Valero-Saldaña
L.M. Valero-Saldaña
ECE. Calderon-Flores
E. Calderon-Flores